Danielle M. Bello

1.1k total citations
23 papers, 451 citations indexed

About

Danielle M. Bello is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Danielle M. Bello has authored 23 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Danielle M. Bello's work include Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (8 papers) and Nonmelanoma Skin Cancer Studies (6 papers). Danielle M. Bello is often cited by papers focused on Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (8 papers) and Nonmelanoma Skin Cancer Studies (6 papers). Danielle M. Bello collaborates with scholars based in United States and Austria. Danielle M. Bello's co-authors include Charlotte E. Ariyan, Richard D. Carvajal, Mark B. Faries, Daniel G. Coit, Mary S. Brady, Katherine S. Panageas, Joanne F. Chou, Daniel C. Thomas, Larissa K. Temple and Daniel Pérez and has published in prestigious journals such as Journal of Clinical Oncology, British journal of surgery and JAMA Psychiatry.

In The Last Decade

Danielle M. Bello

20 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle M. Bello United States 12 401 145 118 110 74 23 451
Burkhard Bueltmann Germany 6 252 0.6× 121 0.8× 90 0.8× 74 0.7× 47 0.6× 10 318
Jiro Uehara Japan 12 382 1.0× 186 1.3× 90 0.8× 137 1.2× 110 1.5× 29 488
Sasha D. Girouard United States 9 143 0.4× 154 1.1× 70 0.6× 65 0.6× 87 1.2× 10 315
John Spillane Australia 11 280 0.7× 148 1.0× 54 0.5× 43 0.4× 40 0.5× 23 369
Emily A. Merkel United States 11 244 0.6× 145 1.0× 51 0.4× 53 0.5× 89 1.2× 17 340
Sarah J. Kurley United States 12 322 0.8× 277 1.9× 161 1.4× 61 0.6× 104 1.4× 25 514
Elisabeth Hardy France 7 299 0.7× 163 1.1× 55 0.5× 54 0.5× 78 1.1× 10 470
Vuk Fait Czechia 6 284 0.7× 61 0.4× 122 1.0× 46 0.4× 59 0.8× 10 354
David Speakman Australia 14 310 0.8× 110 0.8× 62 0.5× 52 0.5× 36 0.5× 30 423
Florian Schenck Germany 8 244 0.6× 96 0.7× 48 0.4× 95 0.9× 98 1.3× 12 325

Countries citing papers authored by Danielle M. Bello

Since Specialization
Citations

This map shows the geographic impact of Danielle M. Bello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle M. Bello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle M. Bello more than expected).

Fields of papers citing papers by Danielle M. Bello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle M. Bello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle M. Bello. The network helps show where Danielle M. Bello may publish in the future.

Co-authorship network of co-authors of Danielle M. Bello

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle M. Bello. A scholar is included among the top collaborators of Danielle M. Bello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle M. Bello. Danielle M. Bello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartlett, Edmund K., Nigel P. Barker, Charlotte E. Ariyan, et al.. (2025). Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma. Annals of Surgical Oncology.
2.
Bello, Danielle M., et al.. (2025). Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation. JAMA Psychiatry. 82(8). 768–768.
3.
Bartlett, Edmund K., Nigel P. Barker, Charlotte E. Ariyan, et al.. (2025). Local Recurrence Following Complete Surgical Excision of Primary Merkel Cell Carcinoma. Annals of Surgical Oncology.
4.
Kurtansky, Nicholas R., Emily R. Nadelmann, Andrea P. Moy, et al.. (2024). Declining Clinical Utility of Tools for Predicting Sentinel Lymph Node Biopsy Status: A Single Institution Experience from 2000 to 2021. Annals of Surgical Oncology. 32(3). 1463–1472. 2 indexed citations
5.
Kurtansky, Nicholas R., Emily R. Nadelmann, Andrea P. Moy, et al.. (2023). Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms. Journal of the American College of Surgeons. 238(1). 23–31. 5 indexed citations
6.
Flynn, Jessica, Katherine S. Panageas, Armin Shahrokni, et al.. (2021). Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma. Annals of Surgical Oncology. 28(13). 9031–9038. 4 indexed citations
7.
Thomas, Daniel C. & Danielle M. Bello. (2021). Adjuvant immunotherapy for melanoma. Journal of Surgical Oncology. 123(3). 789–797. 22 indexed citations
8.
Bartlett, Edmund K., Ann Y. Lee, Philip M. Spanheimer, et al.. (2020). Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. British journal of surgery. 107(11). 1480–1488. 9 indexed citations
9.
Bello, Danielle M. & Mark B. Faries. (2019). The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes). Annals of Surgical Oncology. 27(1). 15–21. 53 indexed citations
10.
Bello, Danielle M., Katherine S. Panageas, Travis J. Hollmann, et al.. (2019). Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade. Annals of Surgical Oncology. 27(4). 1180–1188. 36 indexed citations
11.
Bello, Danielle M., et al.. (2018). Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology. Annals of Surgical Oncology. 25(10). 2884–2889. 22 indexed citations
12.
Bello, Danielle M. & Charlotte E. Ariyan. (2018). Adjuvant Therapy in the Treatment of Melanoma. Annals of Surgical Oncology. 25(7). 1807–1813. 5 indexed citations
13.
Bello, Danielle M., Gang Han, Laura Jackson, et al.. (2016). The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Annals of Surgical Oncology. 23(S5). 938–945. 23 indexed citations
14.
Bello, Danielle M., Ronald P. DeMatteo, & Charlotte E. Ariyan. (2014). The GIST of Targeted Therapy for Malignant Melanoma. Annals of Surgical Oncology. 21(6). 2059–2067. 10 indexed citations
15.
Ariyan, Charlotte E., Robert A. Lefkowitz, Katherine S. Panageas, et al.. (2014). Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma.. Journal of Clinical Oncology. 32(15_suppl). 9078–9078. 11 indexed citations
16.
Bello, Danielle M., Joanne F. Chou, Katherine S. Panageas, et al.. (2013). Prognosis of Acral Melanoma: A Series of 281 Patients. Annals of Surgical Oncology. 20(11). 3618–3625. 108 indexed citations
17.
Pérez, Daniel, Atthaphorn Trakarnsanga, Jinru Shia, et al.. (2013). Locoregional Lymphadenectomy in the Surgical Management of Anorectal Melanoma. Annals of Surgical Oncology. 20(7). 2339–2344. 36 indexed citations
18.
Bello, Danielle M., Elizabeth Smyth, Daniel Pérez, et al.. (2013). Anal Versus Rectal Melanoma. Diseases of the Colon & Rectum. 56(2). 150–157. 47 indexed citations
19.
Schindler, Katja, Kaan Harmankaya, Michael A. Postow, et al.. (2013). Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody.. Journal of Clinical Oncology. 31(15_suppl). 9024–9024. 24 indexed citations
20.
Bello, Danielle M., Charlotte E. Ariyan, & Richard D. Carvajal. (2013). Melanoma Mutagenesis and Aberrant Cell Signaling. Cancer Control. 20(4). 261–281. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Burkhard Bueltmann Breakdown of academic impact, for papers by Jiro Uehara Breakdown of academic impact, for papers by Sasha D. Girouard Breakdown of academic impact, for papers by John Spillane Breakdown of academic impact, for papers by Emily A. Merkel Breakdown of academic impact, for papers by Sarah J. Kurley Breakdown of academic impact, for papers by Elisabeth Hardy Breakdown of academic impact, for papers by Vuk Fait Breakdown of academic impact, for papers by David Speakman Breakdown of academic impact, for papers by Florian Schenck
Rankless by CCL
2026